Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nesina (alogliptin) long-term use surveillance in type 2 diabetes mellitus (monotherapy or with alpha-glucosidase inhibitor)
jRCT1080222203Completed
- Sponsor
- Takeda
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of alogliptin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Takeda. Started Aug 2013; status: completed.
02
Drugs
alogliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT1080222203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080222203.